News
Archive
Finally, Graphene electronic devices available for all
Ventyx Biosciences reports clinical data for its NLRP3 inhibitor portfolio and provides pipeline updates at virtual investor event
NorthSea Therapeutics initiates Phase 2A trial of Orziloben (NST-6179) in Intestinal Failure-Associated Liver Disease (IFALD)
Resolve Therapeutics announces publication of Lupus clinical trial results
biomodal delivers the 6-base genome with a powerful new multiomic solution, duet evoC
InvestEU in Belgium: EIB venture debt for bone therapy innovator Novadip
Back To News
October 30, 2017
When Silicon Valley came to Wall Street
Gilead Sciences recently reached an $11.9bn agreement to acquire Kite Pharma for a 50 per cent premium to its monthly average stock price. Five days before the US takeover was announced, an artificially intelligent computer predicted it. The algorithm, developed by Dataminr, a New York-based technology group, had noticed unusual social media chatter and options … Continue reading “When Silicon Valley came to Wall Street”
The post When Silicon Valley came to Wall Street appeared first on Fuzzy Logix.